Granules India per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹27.06₹24.47₹20.69₹16.73₹21.05
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹26.92₹24.46₹20.68₹16.72₹21.00
₹205.21₹205.21₹153.19₹133.08₹117.13
₹227.29₹216.53₹184.78₹185.93₹186.41
—₹32.01₹35.73₹18.13₹30.52
₹9.49₹9.49₹12.16₹2.43₹13.55
—₹1.47₹1.50₹1.50₹0.77
24.824.824.324.224.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

GRANULES₹840.45

Granules India Ltd.

· Pharma & Health
₹ CrorePeersAUROPHARMAIPCALABAARTIDRUGSERISINDGNEMCUREJUBLPHARMACONCORDBIOMcap ₹20,826 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS21.0516.7320.6924.4727.06
Diluted EPS21.0016.7220.6824.4626.92
Book Value per Share117.13133.08153.19205.21205.21
Revenue per Share186.41185.93184.78216.53227.29
Cash Flow per Share30.5218.1335.7332.01—
Free Cash Flow per Share13.552.4312.169.499.49
Dividends per Share0.771.501.501.47—
Shares Outstanding (cr)24.224.224.324.824.8
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.